On January 14, 2025, the federal government sued Capital One, accusing it of deceptive practices related to its “360 Savings” accounts. Consumer Financial Protection Bureau v. Capital One Financial Corp., No. 25-cv-00061...more
Manufacturers of goods and their attorneys are keeping close watch on the case developing between Woodman's Markets and Clorox. At issue is a manufacturer's ability to use large-packaged goods to work around the price...more
Last year’s Supreme Court decision in FTC v. Actavis cleared the way for more antitrust challenges to settlements between generic and branded pharmaceutical companies resolving Hatch-Waxman patent litigation. As a result,...more
7/11/2014
/ Antitrust Litigation ,
Corporate Counsel ,
Enforcement ,
Enforcement Actions ,
Federal Trade Commission (FTC) ,
FTC v Actavis ,
Hatch-Waxman ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
SCOTUS ,
Settlement
In this Issue:
- Focus On The Federal Trade Commission
- Supreme Court Decision in FTC v. Actavis Provides Guidance on Pay-for-Delay
- DOJ Prevails on Liability in eBooks Antitrust Case in the Southern District...more
7/1/2013
/ Actavis Inc. ,
Dawn Raids ,
Department of Justice (DOJ) ,
EU ,
Federal Trade Commission (FTC) ,
FTC v Actavis ,
FTC v. Phoebe Putney Health System ,
Hospital Mergers ,
Pay-For-Delay ,
Price-Fixing ,
Reverse Payment Settlement Agreements ,
SCOTUS ,
State Action Doctrine ,
Unfair Competition